Health Care & Life Sciences » Biotechnology | Changzhou Qianhong Bio-Pharma Co. Ltd.

Changzhou Qianhong Bio-Pharma Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
854
804
747
767
1,049
1,305
Cost of Goods Sold (COGS) incl. D&A
501
344
256
283
536
709
Gross Income
352
460
491
483
513
595
SG&A Expense
203
273
291
325
390
473
EBIT
144
202
202
161
121
122
Unusual Expense
-
-
-
1
1
1
Non Operating Income/Expense
6
1
5
4
3
27
Interest Expense
1
1
9
17
17
19
Pretax Income
216
286
303
265
214
254
Income Tax
34
44
41
40
39
43
Consolidated Net Income
182
242
262
225
175
211
Net Income
187
245
267
224
183
221
Net Income After Extraordinaries
187
245
267
224
183
221
Net Income Available to Common
187
245
267
224
183
221
EPS (Basic)
0.15
0.19
0.21
0.18
0.14
0.17
Basic Shares Outstanding
1,280
1,280
1,280
1,280
1,274
1,268
EPS (Diluted)
0.15
0.19
0.21
0.18
0.14
0.17
Diluted Shares Outstanding
1,280
1,280
1,280
1,280
1,274
1,268
EBITDA
166
224
223
188
184
185
Other Operating Expense
5
14
2
3
2
-
Non-Operating Interest Income
72
85
105
117
112
122
Minority Interest Expense
-
5
3
5
8
10

About Changzhou Qianhong Bio-Pharma Co.

View Profile
Address
No. 518 Yunhe Road
Changzhou Jiangsu 213125
China
Employees -
Website http://www.qhsh.com.cn
Updated 07/08/2019
Changzhou Qianhong Biopharma Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. It focuses on polysaccharides and enzymes. Its business scope covers lyophilized powder for injections, small volume parenteral solutions, tablets, hard capsules, granules, and active pharmaceutical ingredient (API) products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.